Gene · 1398
Papers2,784
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,784
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Comprehensive Kinase Activity Profiling Revealed the Kinase Activity Patterns Associated with the Effects of EGFR Tyrosine Kinase Inhibitor Therapy in Advanced Non-Small-Cell Lung Cancer Patients with Sensitizing EGFR Mutations. | Proteomes | 2023 | 36810562 | PubTator, text mining | PubMed |
| An in vivo phosphoregulation paradox for focal adhesions. | J Cell Biol | 2023 | 36795454 | PubTator, text mining | PubMed |
| Nano-formulations for bone-specific delivery of siRNA for CrkII silencing-induced regulation of bone formation and resorption to maximize therapeutic potential for bone-related diseases. | Biomater Sci | 2023 | 36794531 | PubTator, text mining | PubMed |
| ALK fusion NSCLC oncogenes promote survival and inhibit NK cell responses via SERPINB4 expression. | Proc Natl Acad Sci U S A | 2023 | 36791109 | PubTator, text mining | PubMed |
| A novel view of the insulin signaling pathway based on prediction of protein structure by the AI platform AlphaFold. | J Diabetes Investig | 2023 | 36789494 | PubTator, text mining | PubMed |
| A Novel CMY Variant Confers Transferable High-Level Resistance to Ceftazidime-Avibactam in Multidrug-Resistant Escherichia coli. | Microbiol Spectr | 2023 | 36786629 | PubTator, text mining | PubMed |
| The Emerging Role of Cell Adhesion Molecules on Benign Prostatic Hyperplasia. | Int J Mol Sci | 2023 | 36769190 | PubTator, text mining | PubMed |
| Editorial to Special Issue "Glioblastoma: Recapitulating the Key Breakthroughs and Future Perspective". | Int J Mol Sci | 2023 | 36768870 | PubTator, text mining | PubMed |
| Inhibition of Abl Kinase by Imatinib Can Rescue the Compromised Barrier Function of 22q11.2DS Patient-iPSC-Derived Blood-Brain Barriers. | Cells | 2023 | 36766762 | PubTator, text mining | PubMed |
| ABL1/2 and DDR1 Drive MEKi Resistance in NRAS-Mutant Melanomas by Stabilizing RAF/MYC/ETS1 and Promoting RAF Homodimerization. | Cancers (Basel) | 2023 | 36765910 | PubTator, text mining | PubMed |
| Bioinformatics Analysis Reveals a Shared Pathway for Common Forms of Adult Nephrotic Syndrome. | Kidney360 | 2023 | 36763793 | PubTator, text mining | PubMed |
| Extracellular vesicles and high-density lipoproteins: Exercise and oestrogen-responsive small RNA carriers. | J Extracell Vesicles | 2023 | 36739598 | PubTator, text mining | PubMed |
| Crk proteins activate the Rap1 guanine nucleotide exchange factor C3G by segregated adaptor-dependent and -independent mechanisms. | Cell Commun Signal | 2023 | 36737758 | PubTator, text mining | PubMed |
| Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | Mol Cell | 2023 | 36736316 | PubTator, text mining | PubMed |
| Lack of Paxillin phosphorylation promotes single-cell migration in vivo. | J Cell Biol | 2023 | 36723624 | PubTator, text mining | PubMed |
| Termination of TCR-mediated activation signals is regulated by CrkII-dependent Cbl-mediated ubiquitination and degradation of C3G. | Immunobiology | 2023 | 36720192 | PubTator, text mining | PubMed |
| The paradigm of amyloid precursor protein in amyotrophic lateral sclerosis: The potential role of the 682YENPTY687 motif. | Comput Struct Biotechnol J | 2023 | 36698966 | PubTator, text mining | PubMed |
| Exosomal transmission of viruses, a two-edged biological sword. | Cell Commun Signal | 2023 | 36691072 | PubTator, text mining | PubMed |
| Time-resolved RNA signatures of CD4+ T cells in Parkinson's disease. | Cell Death Discov | 2023 | 36681665 | PubTator, text mining | PubMed |
| Identification of Novel CSF-Derived miRNAs in Treated Paediatric Onset Spinal Muscular Atrophy: An Exploratory Study. | Pharmaceutics | 2023 | 36678797 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1398/papers?page=11